{
  "id": 17153847,
  "title": "Limited cross strain CMV protection by a bivalent (gB/pp65) vaccine is based on an impaired gB antibody response and evasion of pp65 cell mediated immunity",
  "url": "https://urgent.news/2026/10/29/limited-cross-strain-cmv-protection-by-a-bivalent-gb-pp65-vaccine-is",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-29T00:00:00.000Z",
  "source": {
    "name": "bioRxiv",
    "slug": "biorxiv",
    "url": "https://www.biorxiv.org/content/10.64898/2026.10.28.762556v1?rss=1"
  },
  "original_language": "en",
  "account": null,
  "summary": "Congenital CMV (cCMV) is a leading cause of hearing loss and cognitive impairment in newborns and a vaccine is a high priority. The guinea pig with species-specific guinea pig cytomegalovirus (GPCMV) is the only small animal model for cCMV. Prior GPCMV vaccine studies have focused on prototype strain 22122 and not evaluated cross-strain protection, an important vaccine benchmark. The essential…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}